Nomograms for Predicting the Risk and Prognosis of Liver Metastases in Pancreatic Cancer: A Population-Based Analysis

被引:3
作者
Shi, Huaqing [1 ]
Li, Xin [2 ]
Chen, Zhou [2 ]
Jiang, Wenkai [1 ]
Dong, Shi [1 ]
He, Ru [2 ]
Zhou, Wence [1 ,3 ]
机构
[1] Lanzhou Univ, Coll Clin Med 2, Lanzhou 730000, Peoples R China
[2] Lanzhou Univ, Clin Med Coll 1, Lanzhou 730030, Peoples R China
[3] Lanzhou Univ, Dept Gen Surg, Hosp 2, Lanzhou 730030, Peoples R China
来源
JOURNAL OF PERSONALIZED MEDICINE | 2023年 / 13卷 / 03期
基金
中国国家自然科学基金;
关键词
nomogram; pancreatic cancer; liver metastases; predictive models; overall survival; SEER database; ADENOCARCINOMA; CARCINOMA; RESECTION; SURVIVAL; MODEL; STATISTICS; RECURRENCE;
D O I
10.3390/jpm13030409
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The liver is the most prevalent location of distant metastasis for pancreatic cancer (PC), which is highly aggressive. Pancreatic cancer with liver metastases (PCLM) patients have a poor prognosis. Furthermore, there is a lack of effective predictive tools for anticipating the diagnostic and prognostic techniques that are needed for the PCLM patients in current clinical work. Therefore, we aimed to construct two nomogram predictive models incorporating common clinical indicators to anticipate the risk factors and prognosis for PCLM patients. Clinicopathological information on pancreatic cancer that referred to patients who had been diagnosed between the years of 2004 and 2015 was extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate logistic regression analyses and a Cox regression analysis were utilized to recognize the independent risk variables and independent predictive factors for the PCLM patients, respectively. Using the independent risk as well as prognostic factors derived from the multivariate regression analysis, we constructed two novel nomogram models for predicting the risk and prognosis of PCLM patients. The area under the curve (AUC) of the receiver operating characteristic (ROC) curve, the consistency index (C-index), and the calibration curve were then utilized to establish the accuracy of the nomograms' predictions and their discriminability between groups. Using a decision curve analysis (DCA), the clinical values of the two predictors were examined. Finally, we utilized Kaplan-Meier curves to examine the effects of different factors on the prognostic overall survival (OS). As many as 1898 PCLM patients were screened. The patient's sex, primary site, histopathological type, grade, T stage, N stage, bone metastases, lung metastases, tumor size, surgical resection, radiotherapy, and chemotherapy were all found to be independent risks variables for PCLM in a multivariate logistic regression analysis. Using a multivariate Cox regression analysis, we discovered that age, histopathological type, grade, bone metastasis, lung metastasis, tumor size, and surgery were all independent prognostic variables for PCLM. According to these factors, two nomogram models were developed to anticipate the prognostic OS as well as the risk variables for the progression of PCLM in PCLM patients, and a web-based version of the prediction model was constructed. The diagnostic nomogram model had a C-index of 0.884 (95% CI: 0.876-0.892); the prognostic model had a C-index of 0.686 (95% CI: 0.648-0.722) in the training cohort and a C-index of 0.705 (95% CI: 0.647-0.758) in the validation cohort. Subsequent AUC, calibration curve, and DCA analyses revealed that the risk and predictive model of PCLM had high accuracy as well as efficacy for clinical application. The nomograms constructed can effectively predict risk and prognosis factors in PCLM patients, which facilitates personalized clinical decision-making for patients.
引用
收藏
页数:18
相关论文
共 77 条
  • [11] Nomograms predicting cancer-specific survival for stage IV colorectal cancer with synchronous lung metastases
    Cheng, Pu
    Chen, Haipeng
    Huang, Fei
    Li, Jiyun
    Liu, Hengchang
    Zheng, Zhaoxu
    Lu, Zhao
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [12] Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to chemotherapy?
    Crippa, S.
    Bittoni, A.
    Sebastiani, E.
    Partelli, S.
    Zanon, S.
    Lanese, A.
    Andrikou, K.
    Muffatti, F.
    Balzano, G.
    Reni, M.
    Cascinu, S.
    Falconi, M.
    [J]. EJSO, 2016, 42 (10): : 1533 - 1539
  • [13] Lack of Transparency and Potential Bias in Artificial Intelligence Data Sets and Algorithms A Scoping Review
    Daneshjou, Roxana
    Smith, Mary P.
    Sun, Mary D.
    Rotemberg, Veronica
    Zou, James
    [J]. JAMA DERMATOLOGY, 2021, 157 (11) : 1362 - 1369
  • [14] Parameter estimation for WMTI-Watson model of white matter using encoder-decoder recurrent neural network
    Diao, Yujian
    Jelescu, Ileana
    [J]. MAGNETIC RESONANCE IN MEDICINE, 2023, 89 (03) : 1193 - 1206
  • [15] Disibio G, 2008, ARCH PATHOL LAB MED, V132, P931, DOI 10.1043/1543-2165(2008)132[931:MPOCRF]2.0.CO
  • [16] 2
  • [17] A radiomics nomogram for predicting the meningioma grade based on enhanced T1WI images
    Duan, Chongfeng
    Zhou, Xiaoming
    Wang, Jiachen
    Li, Nan
    Liu, Fang
    Gao, Song
    Liu, Xuejun
    Xu, Wenjian
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2022, 95 (1137)
  • [18] Potentiality of raloxifene loaded melittin functionalized lipidic nanovesicles against pancreatic cancer cells
    Fahmy, Usama A.
    Badr-Eldin, Shaimaa M.
    Aldawsari, Hibah M.
    Alhakamy, Nabil A.
    Ahmed, Osama A. A.
    Radwan, Mohamed F.
    Eid, Basma G.
    Sayed, Shaban R. M.
    El Sherbiny, Gamal A.
    Abualsunun, Walaa
    [J]. DRUG DELIVERY, 2022, 29 (01) : 1863 - 1877
  • [19] More deaths from pancreatic cancer than breast cancer in the EU by 2017
    Ferlay, J.
    Partensky, C.
    Bray, F.
    [J]. ACTA ONCOLOGICA, 2016, 55 (9-10) : 1158 - 1160
  • [20] Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?
    Gleisner, Ana Luiza
    Assumpcao, Lia
    Cameron, John L.
    Wolfgang, Christopher L.
    Choti, Michael A.
    Herman, Joseph M.
    Schulick, Richard D.
    Pawlik, Timothy M.
    [J]. CANCER, 2007, 110 (11) : 2484 - 2492